Cytek Biosciences Executive and Leadership Team

Wenbin Jiang, the Chief Executive Officer & Chairman at Cytek Biosciences, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the development of Full Spectrum Profiling technology, Jiang ensures the company maintains a competitive edge in the global biotechnology sector. This leadership role involves constant collaboration with the Board to align operational goals with market demands for high-sensitivity cell analysis tools. Wenbin Jiang manages the expansion of the product portfolio, including the Aurora and Northern Lights systems, to meet the evolving needs of scientific research laboratories. Through rigorous oversight of international operations across North America, Europe, and Asia, the Chief Executive Officer & Chairman secures the company's position as a leader in cell analysis solutions. Strategic decision-making remains central to the growth trajectory, ensuring that all research and development initiatives support the broader mission of advancing scientific discovery.

William McCombe, the Chief Financial Officer at Cytek Biosciences, manages the financial health and capital allocation strategies for the organization. By overseeing fiscal planning and investor relations, McCombe ensures the company possesses the necessary resources to scale operations across North America, Europe, and Asia. This leadership role involves analyzing market trends in the biotechnology sector to inform investment in research and development for cell analysis tools. William McCombe directs the financial reporting processes and maintains compliance with international standards, providing transparency to stakeholders regarding the performance of the Aurora and Northern Lights product lines. Through rigorous budget management and risk assessment, the Chief Financial Officer supports the company's growth objectives and long-term sustainability. By optimizing capital structure and operational efficiency, McCombe enables the business to continue delivering high-sensitivity solutions to scientific research laboratories and clinical environments globally.

Ming Yan, the Chief Technology Officer at Cytek Biosciences, architects the technical roadmap for advanced cell analysis instrumentation and software. By driving the innovation of Full Spectrum Profiling, Yan ensures the delivery of high-resolution data to research institutions worldwide. This role involves managing the engineering teams responsible for the Aurora and Northern Lights systems, focusing on increasing sensitivity and throughput for complex biological samples. Ming Yan collaborates with product development units to integrate new reagents and software capabilities that enhance the utility of existing platforms. Overseeing technical operations across global markets, the Chief Technology Officer maintains the integrity of the company's intellectual property and research output. Through continuous evaluation of emerging biotechnology trends, Yan optimizes the technical infrastructure to support both clinical and research applications, ensuring that the product suite remains at the forefront of the scientific research services sector.

Valerie Barnett, the Chief Legal Officer at Cytek Biosciences, directs all legal affairs, intellectual property protection, and corporate governance initiatives. By overseeing the regulatory landscape for biotechnology products, Barnett ensures that the company adheres to strict standards in both research and clinical markets, including the Northern Lights CLC system usage in the European Union and China. This role involves managing complex contract negotiations and safeguarding the patented Full Spectrum Profiling technology against infringement. Valerie Barnett collaborates with executive leadership to mitigate operational risks and ensure compliance with international trade laws across global offices. Through the development of robust legal frameworks, the Chief Legal Officer supports the company's expansion into new scientific research services. By providing strategic counsel on mergers, acquisitions, and partnerships, Barnett protects the organization's assets and facilitates the secure delivery of cell analysis solutions to a diverse, global customer base.

Connie Wedel, the Chief People Officer at Cytek Biosciences, directs the human capital strategy, talent acquisition, and organizational development initiatives. By overseeing the recruitment of specialized scientific and engineering talent, Wedel ensures the company maintains the expertise required to innovate in the field of cell analysis. This role involves fostering a culture of excellence that aligns with the mission of providing high-resolution tools to research institutions. Connie Wedel manages global workforce planning across North America, Europe, and Asia, ensuring that internal teams possess the skills to support the Aurora and Northern Lights product portfolios. Through the implementation of professional development programs and performance management systems, the Chief People Officer drives employee engagement and operational productivity. By optimizing organizational structure and internal communication, Wedel supports the company's growth and ensures that the workforce remains focused on delivering high-sensitivity solutions to the biotechnology market.